These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26188162)

  • 1. Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic?
    Trivedi RB; Humphreys K
    Contemp Clin Trials; 2015 Sep; 44():20-25. PubMed ID: 26188162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis.
    Moberg CA; Humphreys K
    Drug Alcohol Rev; 2017 May; 36(3):378-388. PubMed ID: 27324921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies.
    Humphreys K; Weisner C
    Am J Psychiatry; 2000 Apr; 157(4):588-94. PubMed ID: 10739418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain.
    Salmasi V; Lii TR; Humphreys K; Reddy V; Mackey SC
    Pain Rep; 2022; 7(6):e1050. PubMed ID: 36398200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The exclusion of people with psychiatric disorders from medical research.
    Humphreys K; Blodgett JC; Roberts LW
    J Psychiatr Res; 2015 Nov; 70():28-32. PubMed ID: 26424420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusion criteria and generalizability in bipolar disorder treatment trials.
    Wong JJ; Jones N; Timko C; Humphreys K
    Contemp Clin Trials Commun; 2018 Mar; 9():130-134. PubMed ID: 29696235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis.
    Perry DC; Sturm VE; Peterson MJ; Pieper CF; Bullock T; Boeve BF; Miller BL; Guskiewicz KM; Berger MS; Kramer JH; Welsh-Bohmer KA
    J Neurosurg; 2016 Feb; 124(2):511-26. PubMed ID: 26315003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Impact of Exclusion Criteria on the Generalizability of Schizophrenia Treatment Research.
    Humphreys K
    Clin Schizophr Relat Psychoses; 2017; 11(1):49-57. PubMed ID: 28548580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98.
    Humphreys K; Weingardt KR; Horst D; Joshi AA; Finney JW
    Addiction; 2005 Sep; 100(9):1249-57. PubMed ID: 16128714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hoertel N; Le Strat Y; Lavaud P; Dubertret C; Limosin F
    J Clin Psychiatry; 2013 Mar; 74(3):265-70. PubMed ID: 23561233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who gets recruited in mild traumatic brain injury research?
    Luoto TM; Tenovuo O; Kataja A; Brander A; Öhman J; Iverson GL
    J Neurotrauma; 2013 Jan; 30(1):11-6. PubMed ID: 22909262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of exclusion criteria in antidepressant clinical trials: a replication study.
    Zetin M; Hoepner CT
    J Clin Psychopharmacol; 2007 Jun; 27(3):295-301. PubMed ID: 17502778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included.
    Zimmerman M; Chelminski I; Posternak MA
    J Nerv Ment Dis; 2004 Feb; 192(2):87-94. PubMed ID: 14770052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion and exclusion criteria in randomized controlled trials of psychotherapy for PTSD.
    Ronconi JM; Shiner B; Watts BV
    J Psychiatr Pract; 2014 Jan; 20(1):25-37. PubMed ID: 24419308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of contextual factors in the rehabilitation of adolescent survivors of traumatic brain injury: emerging concepts identified through modified narrative review.
    Ciccia AH; Threats T
    Int J Lang Commun Disord; 2015 Jul; 50(4):436-51. PubMed ID: 25721403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttraumatic stress disorder treatment outcome research: The study of unrepresentative samples?
    Spinazzola J; Blaustein M; van der Kolk BA
    J Trauma Stress; 2005 Oct; 18(5):425-36. PubMed ID: 16281240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disappearing subject: exclusion of people with cognitive impairment and dementia from geriatrics research.
    Taylor JS; DeMers SM; Vig EK; Borson S
    J Am Geriatr Soc; 2012 Mar; 60(3):413-9. PubMed ID: 22288835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.